Elevated Ki67 (MIB-1) labeling index represents a characteristic feature of small-cell lung cancer (SCLC) and is useful in differentiating it from neuroendocrine cancers of low and intermediate grades [41,43]. This evidence concerns the gene MIB1 and small cell lung carcinoma.